Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UC Irvine
- Dates
- study startedestimated completion
- Principal Investigator
- by Daniela Bota (uci)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UC Cancer
- Daniela Bota (uci)
Professor, Neurology. Authored (or co-authored) 78 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Ono Pharmaceutical Co. Ltd
- Links
- Related Info
- ID
- NCT04947319
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Last Updated